Karl S Peggs, MB, BCh, MA, MRCP, FRCPath
Director,
Adult Stem Cell Transplantation Services
University College London Cancer Institute
NHS Foundation Trust,
London UK
Dr. Karl Peggs is a Senior Lecturer in Stem Cell Transplantation and Immunotherapy at University College London (UCL) and Honorary Consultant in Haematology/Transplantation at UCL Hospitals. He received his preclinical training and MA at Cambridge University, completing his clinical training at Oxford University Medical School. Following qualification he completed general medical training at Addenbrookes Hospital Cambridge, and specialist haematology training at the John Radcliffe Hospital, Oxford University and subsequently UCLH, London. During this time he spent three years in the research group of Professor Stephen Mackinnon, establishing adoptive cellular therapies for cytomegalovirus. After taking the position of Senior Lecturer at UCL in 2003, he spent 2 years at Memorial Sloan Kettering Cancer Institute, New York, in the laboratory of Nobel Laureate Professor James Allison, studying murine models of regulatory checkpoint blockade.
His research interests include immune reconstitution, pathogen-specific adoptive cellular therapies, Hodgkin’s and non-Hodgkin’s lymphomas, Adoptive cellular therapy and regulatory checkpoint-directed immunotherapeutics, He is member of the Leukaemia and Lymphoma Research Clinical Trials Committee, a Trustee of the Teens Unite charity, and has contributed to several international working parties on infectious complications and relapse following stem cell transplantation. He is Chief Investigator for 4 UKCRN national studies investigating transplantation in Hodgkin Lymphoma and cellular therapies for cytomegalovirus.